All patients had at least one mutation. Mutations were mostly found in TP53 (91%) and RB1 (64%).94% of mutations detected in tumor DNA were also detected in the paired ctDNA sample.High cfDNA levels in SCLC patients were associated with significantly worse PFS and OS. The gene discussed is TP53; the disease is neoplasm.